OHI241220C33000
- 7.20
- 0.000.00%
Omega Healthcare Investors Inc Newsroom
Omega Healthcare Is Maintained at Sector Perform by RBC Capital
Omega Healthcare Invts Analyst Ratings
BofA Securities Maintains Omega Healthcare Investors Inc(OHI.US) With Hold Rating, Raises Target Price to $43
RBC Capital Adjusts Price Target on Omega Healthcare Investors to $43 From $39, Says 'Better Investment Trends Driving Stronger Growth Outlook'; Keeps Sector Perform Rating
Truist Financial Maintains Omega Healthcare Investors Inc(OHI.US) With Hold Rating
BNP Paribas Upgrades Omega Healthcare Investors Inc(OHI.US) to Buy Rating, Raises Target Price to $49
BMO Capital Maintains Omega Healthcare Investors Inc(OHI.US) With Hold Rating, Maintains Target Price $45
BMO Capital Maintains Omega Healthcare Investors Inc(OHI.US) With Hold Rating, Raises Target Price to $45
Omega Healthcare Is Maintained at Market Perform by BMO Capital
Omega Healthcare Invts Analyst Ratings
Wells Fargo Maintains Omega Healthcare Investors Inc(OHI.US) With Buy Rating, Raises Target Price to $43
Omega Healthcare Price Target Raised to $39.00/Share From $33.00 by Truist Securities
Omega Healthcare Invts Analyst Ratings
Scotiabank Maintains Omega Healthcare Investors Inc(OHI.US) With Hold Rating, Raises Target Price to $39
Wells Fargo Maintains Omega Healthcare Investors Inc(OHI.US) With Buy Rating, Raises Target Price to $40
Citi Initiates Omega Healthcare Investors Inc(OHI.US) With Buy Rating, Announces Target Price $42
Scotiabank Reaffirms Their Hold Rating on Omega Healthcare (OHI)
Truist Financial Maintains Omega Healthcare Investors Inc(OHI.US) With Hold Rating
BMO Capital Maintains Omega Healthcare Investors Inc(OHI.US) With Hold Rating, Raises Target Price to $39
Mizuho Downgrades Omega Healthcare Investors to Neutral From Outperform, Adjusts Price Target to $35 From $34